You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gemtuzumab

Showing 26 - 50 of 112
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Novo Acute Myeloid Leukemia Trial in Spain (Mylotarg)

Completed
Has Results
  • Novo Acute Myeloid Leukemia
  • Badalona, Barcelona, Spain
  • +5 more
Jan 26, 2021

Leukemia Trial in United States (arsenic trioxide, gemtuzumab ozogamicin, mercaptopurine)

Completed
Has Results
  • Leukemia
  • arsenic trioxide
  • +4 more
  • Roseville, California
  • +191 more
Dec 14, 2022

Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • +13 more
  • Burbank, California
  • +176 more
Mar 25, 2022

Acute Myeloid Leukaemia Trial in Worldwide (Gemtuzumab ozogamicin, Liposomal daunorubicin, Mitoxantrone)

Recruiting
  • Acute Myeloid Leukaemia
  • Gemtuzumab ozogamicin
  • +6 more
  • Adelaide, Australia
  • +67 more
Sep 30, 2021

Acute Myeloid Leukemia Trial in Heidelberg (Bortezomib, Gemtuzumab Ozogamicin)

Recruiting
  • Acute Myeloid Leukemia
  • Heidelberg, Baden-Württemberg, Germany
    University Hospital Heidelberg, Internal Medicine V
May 25, 2020

Reporting of Antibody-Drug Conjugate Associated Sepsis-related

Completed
  • Sepsis (SMQ)
  • +2 more
  • Antibody-Drug Conjugate
  • Antineoplastic and immunomodulating agents other than Antibody-Drug Conjugate
  • Changsha, Hunan, China
    Central South University
Jun 19, 2022

Leukemia Trial in United States (mercaptopurine, methotrexate, tretinoin)

Completed
Has Results
  • Leukemia
  • Scottsdale, Arizona
  • +209 more
Dec 14, 2022

Acute Myeloid Leukemia Trial in Canada, Puerto Rico, United States (procedure, drug, behavioral)

Recruiting
  • Acute Myeloid Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +13 more
  • Birmingham, Alabama
  • +187 more
Apr 28, 2022

Leukemia Trial in Worldwide (asparaginase, cytarabine, daunorubicin HCl)

Completed
Has Results
  • Leukemia
  • Birmingham, Alabama
  • +197 more
Mar 22, 2021

Leukemia, Myeloid, Acute Trial in United States (VCAR33)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • VCAR33
  • La Jolla, California
  • +9 more
Aug 14, 2023

Acute Promyelocytic Leukemia Trial in Worldwide (Mylotarg, Arsenic Trioxide, All-trans retinoic acid)

Recruiting
  • Acute Promyelocytic Leukemia
  • Brussels, Belgium
  • +30 more
Aug 9, 2022

Acute Myeloid Leukemia Trial in La Jolla, Stanford, Atlanta (5-Azacitidine, Gemtuzumab ozogamicin)

Completed
Has Results
  • Acute Myeloid Leukemia
  • La Jolla, California
  • +2 more
Jan 31, 2019

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed
Has Results
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +13 more
  • Stanford, California
  • +3 more
May 2, 2019

Acute Myeloid Leukemia in Children Trial (Standard Intervention, Investigational Intervention)

Not yet recruiting
  • Acute Myeloid Leukemia in Children
  • Standard Intervention
  • Investigational Intervention
  • (no location specified)
Aug 8, 2023

Infusion Reaction, Monoclonal Antibody Trial in Clovis (Montelukast 10 Mg Oral Tablet)

Recruiting
  • Infusion Reaction
  • Monoclonal Antibody
  • Montelukast 10 Mg Oral Tablet
  • Clovis, California
    Community Cancer Institute
Nov 8, 2021

Leukemia Trial in Israel, United States (biological, drug, procedure)

Completed
Has Results
  • Leukemia
  • sargramostim
  • +7 more
  • Birmingham, Alabama
  • +98 more
Oct 23, 2020

Acute Promyelocytic Leukemia Trial in Houston (All-Trans Retinoic Acid (ATRA), Arsenic Trioxide (ATO), Idarubicin)

Completed
Has Results
  • Acute Promyelocytic Leukemia
  • All-Trans Retinoic Acid (ATRA)
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 23, 2019

The Acute Promyelocytic Leukaemia Asian Consortium Project

Recruiting
  • Acute Promyelocytic Leukemia
    • Hong Kong, Hong Kong
      Department of Medicine, the University of Hong Kong, Queen Mary
    Oct 3, 2022

    Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +8 more
    • Gilbert, Arizona
    • +23 more
    Feb 22, 2022

    Acute Myeloid Leukemia (AML) Trial in France

    Not yet recruiting
    • Acute Myeloid Leukemia (AML)
      • Amiens, France
      • +28 more
      Jul 21, 2021

      Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

      Withdrawn
      • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
      • +7 more
      • gemtuzumab ozogamicin
      • laboratory biomarker analysis
      • (no location specified)
      Jun 29, 2018

      Acute Myeloid Leukemia Trial in France (Gemtuzumab ozogamicin (GO))

      Unknown status
      • Acute Myeloid Leukemia
      • Gemtuzumab ozogamicin (GO)
      • Amiens, France
      • +20 more
      Jul 24, 2018

      Acute Myeloid Leukemia Trial in Spain (Quizartinib, Fludarabine, Cytarabine)

      Active, not recruiting
      • Acute Myeloid Leukemia
      • Alicante, Spain
      • +19 more
      Mar 11, 2022

      HIV/AIDS Trial in Guangzhou (Arsenic Trioxide)

      Recruiting
      • HIV/AIDS
      • Arsenic Trioxide
      • Guangzhou, Guangdong, China
        Guangzhou 8th People's Hospital
      Jul 19, 2021

      Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

      Approved for marketing
      • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
      • +9 more
      • gemtuzumab ozogamicin
      • laboratory biomarker analysis
      • Winston-Salem, North Carolina
        Comprehensive Cancer Center of Wake Forest University
      Feb 28, 2018